358 related articles for article (PubMed ID: 21810593)
1. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
[TBL] [Abstract][Full Text] [Related]
2. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
5. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
Zhou G; Cheung AK; Liu X; Huang Y
Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
[TBL] [Abstract][Full Text] [Related]
6. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
[TBL] [Abstract][Full Text] [Related]
9. Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.
Barutta F; Grimaldi S; Gambino R; Vemuri K; Makriyannis A; Annaratone L; di Marzo V; Bruno G; Gruden G
Nephrol Dial Transplant; 2017 Oct; 32(10):1655-1665. PubMed ID: 28387811
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
11. Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy.
Zoja C; Locatelli M; Corna D; Villa S; Rottoli D; Nava V; Verde R; Piscitelli F; Di Marzo V; Fingerle J; Adam JM; Rothenhaeusler B; Ottaviani G; Bénardeau A; Abbate M; Remuzzi G; Benigni A
Nephron; 2016; 132(1):59-69. PubMed ID: 26646377
[TBL] [Abstract][Full Text] [Related]
12. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
13. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
14. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.
Nam BY; Paeng J; Kim SH; Lee SH; Kim DH; Kang HY; Li JJ; Kwak SJ; Park JT; Yoo TH; Han SH; Kim DK; Kang SW
Apoptosis; 2012 Jan; 17(1):1-13. PubMed ID: 22006533
[TBL] [Abstract][Full Text] [Related]
15. Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy.
Du Q; Fu YX; Shu AM; Lv X; Chen YP; Gao YY; Chen J; Wang W; Lv GH; Lu JF; Xu HQ
Life Sci; 2021 May; 272():118808. PubMed ID: 33245967
[TBL] [Abstract][Full Text] [Related]
16. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
17. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.
Zhang J; Gu C; Lawrence DA; Cheung AK; Huang Y
Exp Physiol; 2014 May; 99(5):802-15. PubMed ID: 24443353
[TBL] [Abstract][Full Text] [Related]
18. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
19. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
